Jones anchored her discussion in a core philosophy for veterinary oncology: "one size does not fit all.” According to Jones, ...

Combination Potential: When combined with an anti-PD-1 antibody, Compound 10 significantly inhibited tumor growth, ...

Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics, announced promising preclinical data from the company's novel, ...

A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell therapy may ...

A study published in the Journal of Clinical Oncology confirms that one of the first Food and Drug Administration-approved CAR-T cell therapies offers long-term survival and potential cures for adult ...

A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell therapy may ...

Measuring the lymphocytes - white blood cells that fight infection - in a patient's blood can be used to predict outcomes in ...

In a head-to-head trial, Lilly’s drug was as effective as Imbruvica at inducing responses and displayed certain safety ...

Warren R. Grant helps provide radiation to shrink tumor in dog with Cushing’s disease. University of California-Davis.

In Northwest Alaska, a proposed 211-mile mining road has divided an Inupiaq community already devastated by climate change.